Life sciences company appoints new exec

Life sciences and diagnostics company Danaher appointed Christopher Riley as executive vice president for biotechnology.

Advertisement

Mr. Riley has served with the company since 2007. Prior to his new role, Mr. Riley worked as vice president and group executive for genomics medicine at Danaher, according to an Oct. 31 Danaher news release.

Mr. Riley will begin his position Jan. 1. He will report to Danaher President and CEO Rainer Blair.

At the Becker's 11th Annual IT + Revenue Cycle Conference: The Future of AI & Digital Health, taking place September 14–17 in Chicago, healthcare executives and digital leaders from across the country will come together to explore how AI, interoperability, cybersecurity, and revenue cycle innovation are transforming care delivery, strengthening financial performance, and driving the next era of digital health. Apply for complimentary registration now.

Advertisement

Next Up in Innovation

Advertisement

Comments are closed.